Insider Ownership Details

This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.

Name Shares Options
TAKEDA PHARMACEUTICAL CO LTD 7,459,286 0
Frazier Life Sciences IX, L.P. 7,284,269 0
RA CAPITAL MANAGEMENT, LLC 3,115,008 0
Edwards Jonathan S. By Medicxi Growth I LP 2,019,877 0
Socks David A David A. Socks 2013 Revocable Trust 1,229,346 0
Socks David A David A. Socks 2013 Revocable Trust 1,211,346 0
Nabulsi Azmi 785,700 0
Curran Terrie 64,595 0
Edwards Jonathan S. By Medicxi Growth Co-Invest I LP 47,984 0
Henderson Molly 26,000 0
Parikh Asit 12,500 0
COLA MICHAEL F 9,798 0
FIELDS HEIDI 0 0
Socks David A 0 0
Guzzo Anthony J. 0 0
Heron Patrick J 0 0
0 0
Kohli Aditya 0 0
Stenhouse Mark 0 0
Branning Todd P. 0 0
KARBE FRANK 0 0
Yamada Tadataka 0 0
Topper James N 0 0
Shah Rajeev M. 0 0
 

While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price

Recent Insider Sales

Name Shares Price Date
TAKEDA PHARMACEUTICAL CO LTD 18 19.00 2022 Mar 14
 

Recent Insider Purchases

Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.

Name Shares Price Date
Nabulsi Azmi 20,000 8.16 2022 May 16
Curran Terrie 20,500 7.41 2022 May 13
Henderson Molly 6,000 0.00 2022 May 13
Parikh Asit 12,500 8.00 2022 May 12